You searched for "stone"

1176 results found

Giggle incontinence – not a laughing matter!

For many decades, the condition of giggle incontinence (enuresis risoria, giggle micturition) has remained a rare and poorly understood condition. Patients (90% female) present in their teens, with the history revealing an issue for many years. It is debilitating and...

A Revolution in your hands: Wellspect launch innovative new female catheter

Wellspect have been innovators in catheterisation since developing the world’s first hydrophilic catheter. Now the Swedish company look to revolutionise the way women learn and perform intermittent self-catheterisation (ISC).

Essential Urology: A Guide to Clinical Practice (2nd Edition)

Essential Urology: A Guide to Clinical Practice is an easy read from cover to cover; on average it will take three to four days to finish reading. However, it is packed with information presented in a very succinct manner. The...

BAPU consensus statement on the management of the neuropathic bladder

The summary of this paper states that a “consensus statement is not a guideline nor a method with which to establish what is best practice. It is a way of surveying practice and providing a benchmark for others to compare...

ABU joins BCG in fight against NMIBC recurrence?

The authors test a hypothesis retrospectively in two cohorts of patients with non-muscle invasive bladder cancer (NMIBC), that endogenous bacteria in the bladder might exert antitumour effects, similar to live mycobacteria (BCG), through local immune-related or other mechanisms, on NMIBC...

Dual therapy for OAB in children

Overactive bladder (OAB) is a disorder frequently encountered by the paediatric urologist. Morin et al. report the results of the first known study on the efficacy of mirabegron (a β3 adrenoceptor agonist) as add-on therapy in paediatric patients with refractory...

Viveca Biomed acquires Contrelle Activgard – European market launch imminent!

Viveca Biomed is pleased to announce the imminent relaunch of Contrelle Activgard across Europe, starting with the UK market.

Femeda commence innovative real world clinical trial for Pelviva

A major 330 patient randomised ‘real world’ clinical trial has commenced for Pelviva in conjunction with the University of Manchester and South Manchester GP federation. The trial will compare Pelviva against...

MOWOOT II Intestinal Transit Management System

MOWOOT II is an intermittent colonic exo-peristaltic therapy system for intestinal transit disorders, such as slow transit constipation. MOWOOT II utilises advanced pneumatic technology to treat and prevent chronic constipation without laxatives, enemas...

AvantSonic Z5 & Z3 bladder scanners

Real-time 3D automatic scanners, AvantSonic Z5 & Z3 measure bladder volume and PVR, producing fast and accurate measurements displayed on colour touch screens. Utilising advanced technology, AvantSonic Z5 & Z3...

AvantSonic Z5 & Z3 bladder scanners

Real-time 3D automatic scanners, AvantSonic Z5 & Z3 measure bladder volume and PVR, producing fast and accurate measurements displayed on colour touch screens. Utilising advanced technology, AvantSonic Z5 & Z3...

Study confirms UroShield™ device extremely effective as a bacteriostatic agent

UroShield™ is a breakthrough disposable ultrasound device developed to prevent catheter blockages and biofilm formation, resulting in a reduction in Urinary Tract Infections (UTI) and therefore reducing the need for antibiotics, improving patient outcomes and lowering healthcare costs.